Effect of selective mu1, mu2 and delta2 opioid receptor agonists on gastric functions in the rat
1994; Elsevier BV; Volume: 33; Issue: 8 Linguagem: Inglês
10.1016/0028-3908(94)90155-4
ISSN1873-7064
AutoresGiovanna Improta, Maria Broccardo,
Tópico(s)Pharmacological Receptor Mechanisms and Effects
ResumoBecause the role of mu and delta opioid receptors in modulating gastric functions remains uncertain, we studied whether intracerebroventricular (i.c.v.) and subcutaneous (s.c.) injections of new opioid peptides with high selectivity for mu1 (Lys7-dermorphin), mu2 (Trp4-Asn7-dermorphin) and delta2 (d-Ala2-deltorphin II) opioid receptors would modify gastric secretion (after 2 hr pylorus ligature) and transit (after a phenol red meal) in the rat. Neither i.c.v. nor s.c. injections of the delta2 opioid agonist affected the gastric functions. In contrast, the mu opioid agonists decreased gastric acid secretion and emptying, i.c.v. injections inducing more potent inhibition than s.c. administration. The mu1 selective opioid antagonist naloxonazine had no effect on the inhibition of the gastric secretory and motor response to these peptides but naloxone completely blocked their effects. Our findings suggest (1) that in rats, stimulation of central naloxonazine insensitive opioid receptors (mu2 sites) inhibits gastric acid secretion and emptying; and (2) that delta opioid receptors take no part in mediating these functions.
Referência(s)